539730
FREDUN
Start SIP
Invest Now
Start SIP in FREDUN
Performance
- Low
- ₹1,430
- High
- ₹1,500
- 52 Week Low
- ₹635
- 52 Week High
- ₹1,999
- Open Price₹1,500
- Previous Close₹1,479
- Volume13,389
- 50 DMA₹1,627.86
- 100 DMA₹1,505.70
- 200 DMA₹1,288.87
Investment Returns
- Over 1 Month -15.74%
- Over 3 Month + 0.69%
- Over 6 Month + 70.57%
- Over 1 Year + 105.26%
Smart Investing Starts Here Start SIP with Fredun Pharmaceuticals for Steady Growth!
Fredun Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 23.5
- PEG Ratio
- 0.4
- Market Cap Cr
- 680
- P/B Ratio
- 4.3
- Average True Range
- 98.06
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -46.65
- RSI
- 32.44
- MFI
- 26.85
Fredun Pharmaceuticals Financials
Fredun Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,440.00
-39.05
(-2.64%)
- Bearish Moving Average 13
- Bullish Moving Average 3
- 20 Day
- ₹1,603.43
- 50 Day
- ₹1,627.86
- 100 Day
- ₹1,505.70
- 200 Day
- ₹1,288.87
Resistance and Support
1455.58
- R3 1,550.87
- R2 1,525.28
- R1 1,481.17
- S1 1,411.47
- S2 1,385.88
- S3 1,341.77
Fredun Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-08 | Quarterly Results | |
| 2025-09-25 | Preferential Issue of shares & Others | To consider 1. Issue Of Warrants. alia, to consider a proposal for fund raising up to Rs.120 crores by way of further public offer, rights issue, debt issue, preferential issue or any other method. |
| 2025-07-30 | Quarterly Results | |
| 2025-05-30 | Audited Results & Dividend | |
| 2025-02-04 | Quarterly Results |
Fredun Pharmaceuticals F&O
About Fredun Pharmaceuticals
- NSE Symbol
- FREDUN
- BSE Symbol
- 539730
- Managing Director & CFO
- Mr. Fredun Medhora
- ISIN
- INE194R01017
Similar Stocks to Fredun Pharmaceuticals
Fredun Pharmaceuticals FAQs
Fredun Pharmaceuticals share price is ₹1,440 As on 12 January, 2026 | 02:04
The Market Cap of Fredun Pharmaceuticals is ₹679.9 Cr As on 12 January, 2026 | 02:04
The P/E ratio of Fredun Pharmaceuticals is 23.5 As on 12 January, 2026 | 02:04
The PB ratio of Fredun Pharmaceuticals is 4.3 As on 12 January, 2026 | 02:04
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.